EN
HI
Sai Parenteral's Share price
SAIPARENT
540.8
2.60 (-0.48%)NSE
BSE
Last updated on 21 Aug, 2026 | 12:14 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Sai Parenteral's share price chart
Sai Parenteral's Share Key Metrics
Volume
45936.00
Market Cap
2400.70 CR
LTQ@LTP
29@540.80
ATP
542.81
Var Margin
12.5 %
Circuit Range
434.75-652.05
Delivery %
67.56 %
Value
2.49 CR
ASM/GSM
No
Market Lot
1
Summary
SAIPARENT stock price is ₹540.8 as of 21 Aug, 2026. The stock intraday movement has stayed between ₹540.00 and ₹546.20, while Sai Parenteral's share price 52 week high low is ₹400.00 & ₹706.00.
In terms of trading activity, SAIPARENT share price has recorded a volume of 45,936 shares. The Sai Parenteral's has a market cap of ₹44179231. The stock’s Average Traded Price (ATP) stands at ₹542.81, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 29 @ ₹540.80.
The Sai Parenteral's upper circuit limit is ₹652.05 & The Sai Parenteral's lower circuit limit is ₹434.75, with a Value of ₹2.49 CR. The Delivery Percentage for the day is 67.56%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Sai Parenteral's Resistance and Support
Pivot 543.62
Resistance
First Resistance
547.24
Second Resistance
551.07
Third Resistance
554.69
Support
First Support
539.79
Second Support
536.17
Third Support
532.34
Sai Parenteral's Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-05-23 | Audited Results & Others |
| 2026-04-20 | Others |
Sai Parenteral's News
Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Sai Parenteral's published newspaper notices for its 25th Annual General Meeting and a special resolution. The resolution details the re-allocation of Rs.101.86 crores from IPO proceeds to acquire 60% stakes in Saicriti Pharma and Prathyak Laboratories for manufacturing expansion and R&D.
Aug 20 2026 15:03:44
Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Sai Parenterals reallocated Rs. 101.86 crore of its IPO proceeds to acquire 60% equity stakes in Saicriti Pharma Private Limited and Prathyak Laboratories Private Limited. This strategic move aims to enhance manufacturing facilities and establish an R&D centre more efficiently.
Aug 20 2026 15:00:53
Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Sai Parenteral's has made available the audio recording of its post-earnings conference call for Q1 FY27 results. The call was held on August 12, 2026, and the recording provides insights into the company's performance and management commentary for the quarter.
Aug 12 2026 18:16:02
Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sai Parenterals released Q1 FY27 financial results and strategic business updates. The company is acquiring 60% stakes in two pharma assets, Saicriti Pharma for Rs. 83.83 cr and Prathyak Laboratories for Rs. 18.02 cr, to boost manufacturing capacity and R&D. Funding for its Australian facility is also complete.
Aug 11 2026 22:24:17
Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Change in Management
Sai Parenteral's Board has re-appointed Anil Kumar Karusala as Managing Director and Vijitha Gorrepati as Whole-time Director. Additionally, Kunal Kakumanu was appointed as an Additional and Executive Director. All appointments are for three-year terms.
Aug 11 2026 18:14:58
Sai Parenterals Ltd - 544742 - Board Meeting Outcome for Outcome Of Board Meeting Held On 11Th August, 2026.
Sai Parenterals reported strong Q1 FY27 results, with standalone net profit up 976% YoY to ₹88.75 mn and cons. net profit up 460% YoY to ₹79.23 mn. The board approved acquiring 60% equity in Saicriti Pharma (₹838.34 mn) and Prathyak Laboratories (₹180.23 mn), funding them from reallocated IPO proceeds. A new US subsidiary was also approved.
Aug 11 2026 18:07:11
Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Sai Parenterals will host an earnings conference call on August 12, 2026, at 02:30 p.m. IST. The call will discuss the company's financial and operational performance for Q1 FY27.
Aug 07 2026 16:04:27
Read More
Sai Parenteral's Management
| Name | Position |
|---|---|
| Anil Kumar Karusala | Chairman & Managing Director |
| Vijitha Gorrepati | Whole Time Director |
Sai Parenteral's Similar Stocks
Solara Active Pharma Sciences Ltd.
614.45
-25.55 (3.99%)
Hikal Ltd.
213.68
1.42 (0.67%)
Panacea Biotec Ltd.
405.45
-8.20 (1.98%)
Dr Agarwals Eye Hospital Ltd.
5262.50
-44.50 (0.84%)
Venus Remedies Ltd.
1730.00
-35.60 (2.02%)
Fredun Pharmaceuticals Ltd.
1433.00
-38.80 (2.64%)
Hester Biosciences Ltd.
2387.40
-25.70 (1.07%)
Sai Parenteral's FAQs
The Buying Price of Sai Parenteral's share is 540.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Sai Parenteral's stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sai Parenteral's, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Sai Parenteral's shares is 168.18. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Sai Parenteral's shares is 3.07. Useful to assess the stock's value relative to its book value.
To assess Sai Parenteral's’s valuation compare Sector P/E, P/B which are 69.06 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Sai Parenteral's is 2400.70 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Sai Parenteral's share price is 706.00 & 400.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Sai Parenteral's belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in SAIPARENT
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC